Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6822541 | 0.91 | LMNA (0.37) | TSHRSMN1; SMN2 | |
| SCHEMBL1782707 | 0.90 | LMNA (0.35) | ALDH1A1MAPK1TDP1TSHRSMN1; SMN2 | |
| SCHEMBL11762223 | 0.90 | LMNA (0.35) | ALDH1A1MAPK1TDP1TSHRSMN1; SMN2 | |
| SCHEMBL8812578 | 0.88 | LMNA (0.39) | TSHRSMN1; SMN2 | |
| SCHEMBL8812230 | 0.88 | LMNA (0.39) | TSHRSMN1; SMN2 | |
| SCHEMBL9421367 | 0.86 | — | — | |
| SCHEMBL13847596 | 0.86 | — | — | |
| SCHEMBL7753331 | 0.86 | ALDH1A1 (0.39) | ALDH1A1MAPK1TDP1TSHR | |
| SCHEMBL263198 | 0.86 | — | — | |
| SCHEMBL9332589 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12234253-B2 | Silicone compounds with a substituted amine group and a benefit agent moiety | THE PROCTER & GAMBLE COMPANY (US) | 2025-02-25 | — | — | US | claimed |
| US-20250051370-A1 | SILICONE COMPOUNDS | PROCTER & GAMBLE (US) | 2025-02-13 | — | — | US | claimed |
| US-20220064191-A1 | SILICONE COMPOUNDS | PROCTER & GAMBLE (US) | 2022-03-03 | — | — | US | claimed |
| CN-113244117-B | Compositions providing delayed release of active substances | 诺赛尔股份有限公司 | 2023-10-20 | — | — | CN | disclosed |
| US-8632792-B2 | Cooling sensation agent composition and sensory stimulation agent composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-01-21 | — | — | US | disclosed |
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-05-19 | — | — | US | disclosed |
| WO-2009123355-A2 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-10-08 | — | — | WO | disclosed |
| US-7186782-B2 | Hydrogenation catalyst composition and process for hydrogenation of conjugated diene polymer | TSRC CORPORATION (TW) | 2007-03-06 | — | — | US | disclosed |
| US-20060041079-A1 | Hydrogenation catalyst composition and process for hydrogenation of conjugated diene polymer | TSRC CORPORATION | 2006-02-23 | — | — | US | disclosed |
| US-6881797-B2 | Process for hydrogenation of conjugated diene polymer | TSRC CORPORATION (TW) | 2005-04-19 | — | — | US | disclosed |
| US-20040082727-A1 | Process for hydrogenation of conjugated diene polymer | TSRC CORPORATION (CN) | 2004-04-29 | — | — | US | disclosed |
| EP-1280763-B1 | TRIMETHYLDECENYL COMPOUNDS | KAO CORP (JP) | 2003-11-12 | — | — | EP | disclosed |
| EP-1280763-A1 | TRIMETHYLDECENYL COMPOUNDS | Cognis Deutschland GmbH & Co. KG (DE) | 2003-02-05 | — | — | EP | disclosed |
| WO-2001085672-A1 | TRIMETHYLDECENYL COMPOUNDS | COGNIS DEUTSCHLAND GMBH & CO.KG (DE) | 2001-11-15 | — | — | WO | disclosed |
| US-5998635-A | CATALYTIC CYCLIZATION AN ALDEHYDE WITH A KETENE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1999-12-07 | — | — | US | disclosed |
| US-4021461-A | INSECTICIDES | ZOECON CORPORATION (US) | 1977-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051370-A1 | SILICONE COMPOUNDS | SMCHD1, SRI, SMS | ALDH1A1 3917/4885MAPK1 4178/4885TDP1 2993/4885 |
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TRPA1, HRH1, HRH2 | ALDH1A1 520/4885MAPK1 150/4885TDP1 3995/4885 |
| US-12234253-B2 | Silicone compounds with a substituted amine group and a benefit agent moiety | SMS, SRM, AAAS | ALDH1A1 3361/4885MAPK1 4194/4885TDP1 1530/4885 |
| US-20220064191-A1 | SILICONE COMPOUNDS | SMCHD1, SRI, SMS | ALDH1A1 3917/4885MAPK1 4178/4885TDP1 2993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.